Background-The concept that venous thromboembolism (VTE) and atherosclerosis are 2 completely distinct entities has recently been challenged because patients with VTE have more asymptomatic atherosclerosis and more cardiovascular events than control subjects. We performed a meta-analysis to assess the association between cardiovascular risk factors and VTE. Methods and Results-Medline and EMBASE databases were searched to identify studies that evaluated the prevalence of major cardiovascular risk factors in VTE patients and control subjects. Studies were selected using a priori defined criteria, and each study was reviewed by 2 authors who abstracted data on study characteristics, study quality, and outcomes. Odds ratios or weighted means and 95% confidence intervals (CIs) were then calculated and pooled using a random-effects model. Statistical heterogeneity was evaluated through the use of 2 and I 2 statistics. Twenty-one case-control and cohort studies with a total of 63 552 patients met the inclusion criteria. Compared with control subjects, the risk of VTE was 2.33 for obesity (95% CI, 1.68 to 3.24), 1.51 for hypertension (95% CI, 1.23 to 1.85), 1.42 for diabetes mellitus (95% CI, 1.12 to 1.77), 1.18 for smoking (95% CI, 0.95 to 1.46), and 1.16 for hypercholesterolemia (95% CI, 0.67 to 2.02). Weighted mean high-density lipoprotein cholesterol levels were significantly lower in VTE patients, whereas no difference was observed for total and low-density lipoprotein cholesterol levels. Significant heterogeneity among studies was present in all subgroups except for the diabetes mellitus subgroup. Higher-quality studies were more homogeneous, and significant associations remained unchanged. 
I
t is generally believed that the genesis of venous thromboembolism (VTE) differs from atherosclerotic cardiovascular disease. 1 This concept of 2 distinct disease entities has recently been challenged. Patients with spontaneous VTE have been found to have a higher prevalence of atherosclerosis, defined by the presence of asymptomatic carotid atherosclerotic lesions, than patients with VTE secondary to known risk factors and control subjects. 2 In addition, the long-term incidence of cardiovascular disease has been reported to be higher in patients with idiopathic VTE than in patients with secondary events. 3, 4 These studies suggest that VTE and cardiovascular disorders may share common risk factors and that in some patients at risk for atherosclerosis, VTE might occur as the first symptomatic cardiovascular event. Yet, 2 large cohort studies challenged this hypothesis by showing that the presence of atherosclerosis was not predictive of an increased risk of VTE. 5, 6 Clinical Perspective p 102
In previous studies, only obesity has consistently been demonstrated to be an independent risk factor for venous thromboembolic events. 7, 8 Recently, observational studies also have reported a positive association between diabetes and deep vein thrombosis, 9 arterial hypertension and the risk of pulmonary embolism, 10 and dyslipidemia and VTE. 11, 12 Elevated levels of triglycerides and low high-density lipoprotein (HDL) seem to increase the risk of VTE, whereas increased HDL levels may protect against VTE. 12, 13 Finally, we recently reported on the association between the metabolic syndrome, a cluster of risk factors for atherosclerosis, and unprovoked deep vein thrombosis. 14 From a laboratory perspective, an association between venous and arterial events is plausible because they share common characteristics such as activation of platelets and coagulation. 15 A number of conditions, including the an-tiphospholipid syndrome and hyperhomocysteinemia, predispose to both venous and arterial events. 16 -19 This potential association between VTE, atherosclerosis, and atherothrombosis has obvious clinical implications with respect to screening, risk factor modification, and future therapy. We therefore performed a systematic review of the literature and a meta-analysis to assess the strength of the evidence supporting such an association.
Methods

Study Selection
We identified all published studies that evaluated the prevalence of major cardiovascular risk factors (ie, arterial hypertension, obesity, diabetes mellitus, dyslipidemia, and smoking) in patients with VTE. We conducted a comprehensive literature search of Medline from 1966 through June 2006 and EMBASE from 1980 through June 2006. All searches were carried out without mapping search terms to subject headings. For the first search, text key words were "deep vein thrombosis," "pulmonary embolism," and "venous thromboembolism" and excluded "infant," "newborn," and "fetus." The results of this search were combined with the results of a subsequent search. Terms used in the last search were "arterial hypertension," "blood pressure," "dyslipidemia," "cholesterol," "triglyceride," "diabetes," "hyperglycemia," "impaired glucose tolerance," "obesity," "overweight," and "smoking." The results of the combined search were limited to studies of humans published in English. The list of articles was reviewed independently by 3 investigators. When multiple articles for a single study had been published, we used the latest publication and supplemented it, if necessary, with data from the earlier publications. In addition, a manual review of references from primary or review articles was performed to identify any additional relevant studies. We contacted the authors for missing and additional unpublished data. Only studies within which the diagnosis of VTE was objectively confirmed (ie, ultrasonography or computed tomography for deep vein thrombosis and computed tomography, magnetic resonance imaging, or ventilation/perfusion scan for pulmonary embolism) that had a control group were included in the final data set. We excluded all studies in which the entire population of patients with VTE had a concomitant, known, major risk factor (eg, studies carried out in patients undergoing major surgery or trauma and studies involving pregnant women only). The agreement between reviewers for study selection was assessed by the statistic. 20, 21 
Data Extraction
Data extraction was performed by 2 investigators, and the results were compiled. Disagreement was resolved by consensus and by opinion of a third author if necessary.
Using a standardized data extraction form, we collected the following baseline characteristics for cases and control groups: lead author, publication year, study design, sample size, mean age, variation in age, and sex. One or more of the following risk factors was collected in each study: number and proportion of patients and controls with systolic and/or diastolic arterial hypertension, hypercholesterolemia, hypertriglyceridemia, diabetes mellitus, obesity, and cigarette smoking. If information on the proportion of patients with and without the risk factor was not available, mean levels and standard deviations were extracted for both cases and controls.
Validity and Study Quality Assessment
We developed a priori criteria to assess study quality.
1. Study design. Prospective cohort studies were considered to be of higher quality than retrospective cohort studies. Casecontrol studies that were specifically designed to assess the influence of risk factors on the occurrence of VTE were considered to be of higher quality than studies that used a nested case-control design either by identifying cases with VTE by hospital discharge registers or by using existing patient registries. 2. Quality of measurement of risk factors. Studies that adequately reported methodology of measurement of risk factors were considered to be of higher quality than studies that just reported results. 3. Method of patient enrollment. Studies with consecutive patient enrollment were considered to be of higher quality than those with nonconsecutive enrollment. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Statistical Analysis
We used Review Manager (RevMan, version 4.2 for Windows, Oxford, England; The Cochrane Collaboration, 2003) to pool data for each risk factor. The odds ratio (OR) and 95% confidence interval (CI) were calculated for each study, and results were compared through the use of a random-effects model (DerSimonian and Laird 22 method). When only mean values and SDs for a certain risk factor were provided, we calculated the weighted mean differences (WMD) between cases and controls. Statistical heterogeneity was evaluated with the 2 and the I 2 statistics, which assess the appropriateness of pooling the individual study results. 23 The I 2 value provides an estimate of the amount of variance across studies resulting from heterogeneity rather than chance.
Sensitivity analyses were based on the quality of the studies to assess the robustness of our primary results. We subsequently excluded articles in which risk factors were reported instead of actually measured; we then excluded all retrospective cohort studies and case-control studies that were derived from registries or discharge files. For each step, we assessed statistical heterogeneity.
Results
Study Characteristics
Our initial search yielded 1949 potential literature citations ( Figure 1 ). Of these, 1913 were excluded after scanning titles and abstracts, leaving 36 citations for further evaluation. The interobserver agreement for the study selection was excellent (ϭ0.98). In 4 studies, no comparable data were provided. 10,24 -26 Three studies did not have a control group, 9, 27, 28 whereas in 2 studies, VTE was diagnosed at postmortem examination. 29, 30 Of the remaining 27 studies, 2 were excluded because no objective diagnosis of VTE was made, 31, 32 and 3 studies were excluded because they described the same study group. [33] [34] [35] Additional data were requested from the authors of 2 studies but obtained for only 1 study. 1 Thus, 21 studies were included in the meta-analysis 1,2,7,11-13,36 -50 with a total of 63 552 patients.
The number of patients in each report ranged between 86 and 21 680 (the Table) . The mean patient age varied widely, depending on the inclusion criteria for these studies. Six studies investigated patients Ͻ55 years of age. 12, 36, 40, 41, 43, 50 Four of the studies involved only patients Ͼ45 years of age. 1, 7, 37, 48 The mean age of the other studies ranged between 42 and 70 years. 11,13,38,39,42,44 -47,49 As far as sex was concerned, 8 studies investigated only women, 13,36,39 -41,43,48,50 5 of these in the range of 15 to 50 years of age. 36, 40, 41, 43, 50 In 3 studies, only men were included. 7, 12, 37 All 4 cohort studies were prospective, 1, 7, 48, 49 with a duration of follow-up between 5.6 48 and 26 years. 7 Follow-up was nearly complete in 2 studies, 7, 48 whereas in the study by Frederiksen et al, 49 65% of the original cohort were followed up. The Longitudinal Investigation of Thromboembolism Etiology (LITE) study derived data from the Atherosclerosis in Communities Study (ARIC) and the Cardiovascular Health Study (CHS), with complete follow-up in 86% and 95% of patients, respectively. All studies included healthy subjects. Seventeen studies were case-control studies. 2,11-13,36 -47,50 Eight were designed to evaluate risk factors for VTE. 2, 11, 12, 38, 42, 44, 45, 47 Nine studies used either hospital discharge data 13, 36, 39, 40, 46 or data from registries. 37, 41, 43, 50 In 2 studies, only patients with deep vein thrombosis were included. 38, 44 In only 4 of the 8 incident case-control studies, consecutive patients were enrolled. 2, 38, 44, 45 In all but 1 study, 49 controls were matched for age. Comparison of the prevalence of cardiovascular risk factors between patients with unprovoked VTE and provoked VTE was not possible given the limited number of studies for which this information was available.
Body Mass Index
Fifteen studies investigated the influence of body mass index (BMI) on the occurrence of VTE: 12 case-control studies 11-13,36 -40,42,44,45,50 and 3 cohort studies. 7, 48, 49 In 2 studies, SDs were not provided, and these studies were excluded from analysis. 7, 39 Overall, the studies included 3665 patients with VTE and 31 138 controls. Patients with VTE had a higher mean BMI than controls (WMD, 1.99 kg/m 2 ; 95% CI, 1.51 to 2.47), regardless of whether they were cohort or case-control studies. Statistical heterogeneity among the studies was significant (I 2 ϭ79.6%; PϽ0.00001) but was present only in the case-control studies. In the 9 studies in which the measurement of BMI was adequately described, 11, 13, 36, 37, 40, 42, 45, 48, 50 the WMD for BMI was 1.73 kg/m 2 (95% CI, 1.49 to 1.97) higher in the patients with VTE, again with significant heterogeneity (I 2 ϭ83.9%; PϽ0.00001). However, when we also excluded lower-quality case-control studies, the 3 remaining studies 11, 42, 45 the studies (I 2 ϭ52.4%; Pϭ0.03). When we restricted our analysis to studies that adequately reported the measurement of blood pressure, ie, 3 case-control studies 2,11,39 and 2 cohort studies, 1,7 the effect of hypertension on VTE disappeared (OR, 1.21; 95% CI, 0.92 to 1.52), without statistical heterogeneity (I 2 ϭ46.8%; Pϭ0.11). Analysis of the highest-quality studies did not change the results. A positive association between blood pressure and VTE was found only in the study by Tsai et al, 1 which classified hypertension as Ͼ140/ 90 mm Hg. The other studies used higher cutoff values (Ͼ160/90 mm Hg) and found no effect (Figure 3) .
Diabetes Mellitus
Nine studies evaluated the effect of diabetes mellitus on VTE: 6 case-control studies 2,12,37,39,40,43 and 3 cohort studies 1, 48, 49 with 5990 thrombosis patients and 50 367 controls (Figure 4 ). Overall, a 1.4-fold increased risk was present for patients with diabetes mellitus (OR, 1.42; 95% CI, 1.12 to 1.77), with no significant statistical heterogeneity among the studies (I 2 ϭ15.2%; Pϭ0.31). However, this effect was determined mainly by the results of the cohort studies (Figure 4) . When the cohort studies and 2 case-control studies of higher quality 2, 12 were analyzed, the OR for diabetes mellitus was 1.38 (95% CI, 1.04 to 1.83), again without statistical heterogeneity (I 2 ϭ21.4%; Pϭ0.28).
Smoking
Smoking status was reported in 10 studies: 7 case-control studies 2,12,36,39,41,43,50 and 3 cohort studies 7, 48, 49 with 3760 thrombosis patients and 34 520 controls ( Figure 5 ). Overall, smoking had no effect on VTE in both case-control and cohort studies, and statistical heterogeneity was significant (OR, 
Total Cholesterol
Eleven studies reported total cholesterol levels; 8 were case-control studies, 11-13,38,40,42,45,47 and 3 were cohort studies. 1, 7, 49 The SD was not provided in 1 study, which was excluded from analysis. 7 Mean levels of total cholesterol were not significantly related to VTE (Figure 6 ). In 8 of 10 studies, measurement of fasting cholesterol levels was adequately reported. 1, [11] [12] [13] 38, 42, 45, 47 This finding did not change when these 8 studies were analyzed. Significant statistical heterogeneity was present for both analyses (I 2 ϭ94%; PϽ0.000001 for both analyses).
Four case-control studies used cutoff levels for hypercholesterolemia, 2,13,43,47 with a total number of 1660 cases and 6233 controls. The definition of hypercholesterolemia differed among the studies (Ͼ200, 47 Ͼ240, 2 and Ͼ256 mg/ dL 13 ); hypercholesterolemia was not defined in 1 other study. 43 Again, no effect of hypercholesterolemia on VTE was seen (OR, 1.16; 95% CI, 0.67 to 2.02; I 2 ϭ76.3%; Pϭ0.005).
Triglycerides
Eleven studies measured triglyceride levels to investigate their effect on VTE: 8 case-control studies [11] [12] [13] 38, 40, 42, 45, 47 and 3 cohort studies. 1, 7, 49 No SD was provided in 1 study, which was therefore excluded from analysis. 7 Because the distribution of triglyceride concentrations is generally skewed, we decided not to pool the results of the studies. In most studies, patients with VTE had higher triglyceride levels than controls, with a mean difference of 21.0 mg/dL (95% CI, 11.0 to 31.0) in the case-control studies and 8.6 mg/dL (95% CI, 1.2 to 16.0) in the cohort studies (Figure 7) . In 8 studies, fasting 
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triglyceride levels were adequately measured. 1, 11, 12, 38, 40, 42, 45, 47 In addition, in these studies, triglyceride levels were on average 21.0 mg/dL (95% CI, 10.0 to 31.0) higher in patients with VTE than in controls.
HDL and Low-Density Lipoprotein Cholesterol
Five studies, including 4 case-control studies 12, 13, 40, 45 and 1 cohort study, 49 measured HDL cholesterol levels in 895 cases and 9841 controls. Figure 8 shows that HDL was inversely and consistently correlated with VTE. HDL levels were on average 2.86 mg/dL (95% CI, Ϫ4.34 to Ϫ1.38) lower in patients with VTE than in controls. This relation was stronger after the exclusion of a nested case-control study 41 (WMD, Ϫ3.16 mg/dL; I 2 ϭ27.8%; Pϭ0.24).
Only 3 studies 12,41,45 with 237 VTE patients and 272 controls measured low-density lipoprotein cholesterol levels, with no effect on the occurrence of VTE (WMD, 0.37 mg/dL; 95% CI, Ϫ16.8 to 17.52) and significant statistical heterogeneity (I 2 ϭ85.4%; Pϭ0.001).
Discussion
Major Findings
The results of our meta-analysis suggest that major risk factors for atherothrombotic disease also are significantly associated with VTE. These findings strengthen the hypothesis that cardiovascular risk factors also may be directly involved in the pathogenesis of VTE and corroborate the results of the studies that challenged the common view that atherosclerosis and VTE are 2 completely distinct disease entities. 3, 4, 51, 52 Until now, only obesity has been consistently shown to be a minor risk factor for venous thrombosis, whereas conflicting results have been reported for hypertension, dyslipidemia, diabetes mellitus, and smoking, After pooling the results of all available studies, we not only were able to confirm the association between obesity and VTE (OR, 2.33) but also could demonstrate for the first time an association between VTE and diabetes mellitus, hypertension, low HDL cholesterol, and high triglycerides. The estimated ORs for these variables may be less robust than those reported for established major risk factors for VTE such as cancer or surgery. However, cardiovascular risk factors are more common and often coexist, and as is well known for atherosclerotic disorders, their coexistence is associated with an additive causative effect. Thus, given the multifactorial nature of VTE, it is highly likely that the concomitant action of risk factors for atherothrombosis may be responsible for a substantial proportion of VTE in the general population. This is entirely consistent with the recent evidence of an association between the metabolic syndrome, a cluster of cardiovascular risk factors, and VTE. 14 
Biological Plausibility
What is the biological plausibility of our assumption? The risk of arterial thrombosis in patients with major cardiovascular risk factors is most likely mediated by the presence of an inflammatory state and hypercoagulability. Both increased inflammation and coagulation also may predispose these patients to develop venous thromboembolic events. Obesity, in particular central and abdominal obesity, is associated with increased thrombin formation and decreased fibrinolysis. 53, 54 Obesity also is associated with immobility, another risk factor for thrombosis. Diabetes mellitus often is associated with increased levels of procoagulant factors and the inhibition of endogenous fibrinolysis. [55] [56] [57] [58] [59] [60] The results of a populationbased study, in which the age-adjusted risk for VTE was found to be Ͼ2-fold higher among diabetic patients than in the nondiabetic background population, further support our data. 9 In turn, diabetes mellitus and the metabolic syndrome are increasingly recognized as "inflammatory disorders" that lead to dyslipidemia (characterized by high triglycerides and low HDL cholesterol levels), hypertension, and abnormal blood clotting. It is therefore no surprise that these risk factors also predispose to VTE and can be considered part of the underlying disease process that is associated with cardiovascular disease and venous thromboembolism. Dyslipidemia also is associated with hypercoagulability, endothelial dys- 
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function, and increased platelet aggregation. [61] [62] [63] Observational studies have found a positive association between dyslipidemia and VTE. [11] [12] [13] An association between low HDL cholesterol and recurrent thrombosis has recently been described, further strengthening our findings. 64 
Clinical Relevance
The clinical implications of our findings are potentially important. A significant proportion of VTE, between 26% and 47%, is currently classified as apparently unprovoked in the absence of major known risk factors such as cancer, trauma, surgery or medical illness, or pregnancy. 65 Recognition of cardiovascular risk factors, if proven to be relevant for VTE, may substantially lower these numbers and support new strategies for both primary and secondary prevention of venous thrombosis. Indeed, in contrast to hereditary thrombophilias, these risk factors can be ameliorated with appropriate therapy and lifestyle changes. The role of weight loss and antiplatelet and lipid-lowering therapy needs to be specifically assessed. Studies evaluating the role of aspirin in the secondary prevention of VTE are currently underway, and preliminary evidence exists that statins may be protective against VTE. 15 The obvious mechanism for this protective effect is through improving lipid profiles, but another possibility is that statins may have a direct effect on endothelial function and coagulation. 66 Finally, the reported increased risk of atherothrombosis in these patients further stresses the need for routine evaluation and management of cardiovascular risk.
Study Limitations
Our study has several limitations. A meta-analysis has inherent weaknesses in terms of combining heterogeneous data sets. Our analysis was by necessity restricted to individual risk factors. Therefore, the distinct possibility exists that the strength of association may be weaker with a multifactorial regression analysis. In the present meta-analysis, it was not possible to adjust or stratify for potential confounders. Age, an important risk factor for VTE, is associated with obesity, hypertension, and type 2 diabetes mellitus, as well as being a risk factor for atherothrombotic disease. Although studies included in our analysis enrolled young and old patients, the effect of age on the strength of the association could not be determined. However, when we compared studies that included only young patients with those that enrolled older patients, the effect of major cardiovascular risk factors on VTE was similar. In addition, in studies like LITE, 1 higher BMI and triglycerides were still associated with VTE after adjustment for age, sex, and race. An additional limitation of our study lies in the fact that the presence or absence of well-established provoking factors for VTE often was not reported in detail; therefore, a separate analysis of the association between cardiovascular risk factors and either unprovoked or provoked VTE was impossible. From our initial hypothesis, it is likely that the causal role of risk factors for atherosclerosis, if any, is more important in the former than in the latter group. Future studies should specifically address this question. Furthermore, almost no information on thrombophilia testing was provided in these studies. The potential impact of antiplatelet and lipid-lowering therapy and other antithrombotic medications could not be evaluated. Finally, a chance exists that major cardiovascular risk factors mediated their effect on VTE through atherosclerosis itself. The concomitant effect of coexisting cardiovascular disease could not be assessed in this meta-analysis because information on comorbidity was not uniformly available in the included studies.
Conclusions
Cardiovascular risk factors are associated with an increased risk of VTE. This association between VTE and atherothrombosis has great clinical relevance with respect to individual screening, risk factor modification, and the primary and secondary prevention of VTE. Future prospective studies should further investigate the underlying mechanisms of this relationship.
